Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,214
Closed -$378K 149
2025
Q1
$378K Sell
1,214
-84
-6% -$24.8K 0.14% 102
2024
Q4
$338K Sell
1,298
-131
-9% -$38.9K 0.13% 113
2024
Q3
$460K Buy
1,429
+69
+5% +$22.6K 0.16% 89
2024
Q2
$425K Buy
+1,360
New +$400K 0.16% 91
2023
Q4
$44.8K Buy
+156
New +$42.5K 0.02% 223

Other funds holding AMGN

Hobbs Group Advisors's AMGN Position: Q2 2025 in Review

Hobbs Group Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 1,214 shares — an estimated $378K sold.

Hobbs Group Advisors first reported a position in AMGN in Q4 2023 and held it in 5 quarters. The position peaked at $460K in Q3 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Hobbs Group Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Hobbs Group Advisors sold 1,214 Amgen shares in Q2 2025, an estimated $378K.
  • Hobbs Group Advisors first reported a position in Amgen in Q4 2023 and held it in 5 quarters.
  • Hobbs Group Advisors's Amgen position peaked at $460K in Q3 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Hobbs Group Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.